US 8067473
Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
granted A61KA61K31/4406A61K31/4745
Quick answer
US patent 8067473 (Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4406, A61K31/4745, A61K31/7048, A61P